◼ Archived
Business
🔮 fades ✓
Is Moderna, Merck's mRNA cancer vaccine win the start of a 'personalized medicine revolution'?
Moderna and Merck's mRNA cancer vaccine win marks a new treatment era.
Keytruda
4 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Keytruda
This hub groups 4 separate news trends connected to Keytruda, spanning August 19, 2026 through September 12, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 31 article observations and 29 source signals, led by Business coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Business
🔮 fades ✓
Inhibrx claims first win for long-sought immunotherapy target
Inhibrx’s breakthrough OX40 data lifted response rates yet left the market oddly unimpressed.
◼ Archived
Business
🔮 fades ✓
Summit Packs A Punch For Merck's Keytruda
6 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Merck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma
Shares of Moderna have doubled after its cancer vaccine trial with Merck met key endpoints.